Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
cancer
7
×
crispr
7
×
life sciences
7
×
national blog main
national top stories
boston blog main
national
new york blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
editas medicine
ipo
startups
abbvie
biogen
bristol-myers squibb
cancer immunotherapy
eli lilly
What
bio
roundup
life
science
car
companies
gene
millions
moves
new
patients
talk
therapeutics
therapy
access
acquisitions
advanced
announced
approval
bails
becker
benefiting
billions
biogen’s
biopharmaceutical
black
boston
brand
bridgebio
capacity
capital
cell
ceo
collabs
coming
consolidation
continue
convo
covid
crispr
Language
unset
Current search:
crispr
×
biotech
×
cancer
×
" life sciences "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More